Irbesartan and Oedematous pancreatitis - a phase IV clinical study of FDA data

Summary:

Oedematous pancreatitis is reported only by a few people who take Irbesartan.

The phase IV clinical study analyzes which people take Irbesartan and have Oedematous pancreatitis. It is created by eHealthMe based on reports of 29,449 people who have side effects while taking Irbesartan from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 24, 2023

29,449 people reported to have side effects when taking Irbesartan.
Among them, 2 people (0.01%) have Oedematous pancreatitis.

What is Irbesartan?

Irbesartan has active ingredients of irbesartan. It is often used in high blood pressure. eHealthMe is studying from 29,921 Irbesartan users for its effectiveness, alternative drugs and more.

What is Oedematous pancreatitis?

Oedematous pancreatitis (interstitial inflammation and swelling of pancreas) is found to be associated with 368 drugs and 187 conditions by eHealthMe.

Number of Irbesartan and Oedematous pancreatitis reports submitted per year:

Could Irbesartan cause Oedematous pancreatitis?

Gender of people who have Oedematous pancreatitis when taking Irbesartan *:

female: 50 %
male: 50 %

Age of people who have Oedematous pancreatitis when taking Irbesartan *:

Common drugs people take besides Irbesartan *:

Mirtazapine: 1 person, 50.00%
Lansoprazole: 1 person, 50.00%
Fenofibrate: 1 person, 50.00%
Crestor: 1 person, 50.00%
Byetta: 1 person, 50.00%

Common conditions people have *:

Type 2 Diabetes: 1 person, 50.00%
Dyslipidaemia (abnormal amount of lipids): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Irbesartan and have Oedematous pancreatitis?

Check whether Oedematous pancreatitis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Oedematous pancreatitis and when was it recovered:

Oedematous pancreatitis in Irbesartan

Expand to all the drugs that have ingredients of irbesartan:

Oedematous pancreatitis and drugs with ingredients of irbesartan

Alternative drugs to, pros and cons of Irbesartan:

Irbesartan (29,921 reports)

Common Irbesartan side effects:

Fatigue (feeling of tiredness): 1,762 reports
High blood pressure: 1,752 reports
Diarrhea: 1,629 reports
Weakness: 1,598 reports
Breathing difficulty: 1,553 reports
Dizziness: 1,461 reports

Browse all side effects of Irbesartan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Oedematous pancreatitis treatments and more:

Oedematous pancreatitis (524 reports)

COVID vaccines that are related to Oedematous pancreatitis:

All the drugs that are associated with Oedematous pancreatitis:

Oedematous pancreatitis (368 drugs)

All the conditions that are associated with Oedematous pancreatitis:

Oedematous pancreatitis (187 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on irbesartan (the active ingredients of Irbesartan) and Irbesartan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.